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Klebsiella oxytoca is a known cause of antibiotic-associated
diarrhea1–4 and hemorrhagic colitis.5 The loss of intestinal cell
membrane integrity with colitis may allow translocation of the
bacteria into the blood stream, with further systemic complica-
tions. To deﬁne the extent of this problem in our hospital, we
performed a retrospective chart review evaluating K. oxytoca
bacteremia and the prevalence of symptomatic colitis.
A retrospective study was performed at the University of
Maryland Medical Center in Baltimore, Maryland, between January
2003 and August 2008, after institutional review board approval.
One hundred thirty-six patients were included in the study, 68
patients with K. oxytoca bacteremia and 68 patients with
Staphylococcus aureus bacteremia. These organisms were identiﬁed
using the automated Vitek system. S. aureus, a common cause of
bacteremia in our population, has been implicated in antibiotic-
associated diarrhea.6–8 The patients were a mixed population
including medical and surgical patients, and patients with
malignancies, with similar baseline characteristics, and were ruled
out for Clostridium difﬁcile colitis. In the K. oxytoca group, diarrhea
was present in 42 (62%) patients with bacteremia. In the S. aureus
group, six (9%) of those patients were found to have diarrhea. K.
oxytoca bacteremia was more frequent in Caucasians compared toTable 1
Patient demographics and results
Klebsiella
oxytoca
n = 68 (%)
Staphylococcus
aureus
n = 68 (%)
p-Value OR (95% CI)
Mean age, years 52.7
(SD 19.1)
52.3
(SD 19.5)
0.91
Gender 0.29 0.14
(0.68–3.06)
Male 44 (65) 38 (54)
Female 24 (35) 30 (46)
Race
African American 22 (32) 43 (64) 0.0013 0.32
(0.15–0.69)
Caucasian 40 (59) 25 (37) 0.008 2.45
(1.17–5.19)
Hispanic or Asian 6 (9) 0 (0)
Diarrhea present
during admission
42 (62) 6 (9) <0.001 16.6
(5.9–52.7)
Klebsiella oxytoca bacteremia and diarrhea multivariate analysis
OR Standard
error.
p > jzj 95% CI
Age 1.01 0.014 0.432 0.98–1.04
Gender 1.19 0.59 0.720 0.45–3.14
Race 6.49 3.3 <0.0001 2.39–17.64
Diarrhea 15.42 9.89 <0.0001 4.39–54.2
OR, odds ratio; CI, conﬁdence interval; SD, standard deviation.
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http://dx.doi.org/10.1016/j.ijid.2013.02.003African Americans, but there was no difference with regard to age
and gender (Table 1).
We demonstrated a signiﬁcant association of K. oxytoca
bacteremia with documented diarrhea. These patients had been
exposed to antibiotics prior to the onset of diarrhea; however, it
was not possible to ascertain the full antibiotic regimen for some
patients because many were transferred from outside hospitals. S.
aureus was selected in this study as an antibiotic-associated
diarrhea control. S. aureus commonly causes bacteremia and is an
agent of antibiotic-associated diarrhea.6–9 Patients with infections
from Gram-negative pathogens have similar risk factors to S.
aureus infection, including ventilator-associated pneumonia,
intravenous drug use, and the presence of central venous
catheters.10 Antibiotic treatment for these conditions can lead to
antibiotic-associated diarrhea. Limitations of our study include its
retrospective nature, and also that stool cultures were not sent for
culture of K. oxytoca.
Clinicians should be aware of the predilection of K. oxytoca to
present with bacteremia in the setting of symptomatic diarrhea. As
many of these patients were considered to have antibiotic-
associated diarrhea such as C. difﬁcile colitis, clinicians should be
aware that empiric therapy against C. difﬁcile would be ineffective
against K. oxytoca which requires systemic antibiotic treatment.
Acknowledgements
The authors would like to thank Dr Manhattan Charurat for his
contribution to the statistical analysis in this study.
Ethical approval: The study was approved by the hospital ethics
committee.
Conﬂict of interest: The authors declare that they have no conﬂict
of interest. The study had no funding.
References
1. Hoffmann KM, Deutschmann A, Weitzer C, Joainig MM, Zechner E, Hogenauer C.
Antibiotic-associated hemorrhagic colitis caused by cytotoxin-producing Kleb-
siella oxytoca. Pediatrics 2010;125:e960–3.
2. Joainig MM, Gorkiewicz G, Leitner E, Weberhofer P, Zollner-Schwetz I, Lippe I.
Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with anti-
biotic-associated hemorrhagic colitis or other diseases caused by infections and
from healthy subjects. J Clin Microbiol 2010;48:817–24.
3. Zollner-Schwetz I, Hogenauer C, Joainig M, Weberhofer P, Gorkiwicz G, Valentin
T. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis
2008;47:e74–8.
4. Hogenauer C, Langner C, Beubler E, Lippe IT, Schicho R, Gorkiewicz G. Klebsiella
oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N
Engl J Med 2006;355:2418–26.
5. Philbrick AM, Ernst ME. Amoxicillin-associated hemorrhagic colitis in the
presence of Klebsiella oxytoca. Pharmacotherapy 2007;27:1603–7.
6. Lo TS, Borchardt SM. Antibiotic-associated diarrhea due to methicillin-resistant
Staphylococcus aureus. Diagn Microbiol Infect Dis 2009;63:388–9.
7. Gorkiewicz G. Nosocomial and antibiotic-associated diarrhoea caused by
organisms other than Clostridium difﬁcile. Int J Antimicrob Agents 2009;33(Suppl
1):S37–41.
8. Lin Z, Kotler DP, Schlievert PM, Sordillo EM. Staphylococcal enterocolitis:
forgotten but not gone? Dig Dis Sci 2010;55:1200–7.ternational Society for Infectious Diseases.
Letter to the Editor / International Journal of Infectious Diseases 17 (2013) e472–e473 e4739. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med
2002;346:334–9.
10. Ak O, Batirel A, Ozer S, Colakoglu S. Nosocomial infections and risk factors in the
intensive care unit of a teaching and research hospital: a prospective cohort
study. Med Sci Monit 2011;17:PH29–34.
Eric R. Coxa,*
Seema U. Nayakb
Janaki C. KuruppuaaInstitute of Human Virology, University of Maryland School of
Medicine, 725 W. Lombard Street, Baltimore, MD 21201, USA
bDepartment of Medicine, Johns Hopkins University,
Baltimore, Maryland, USA
Corresponding Editor: Eskild Petersen, Aarhus, Denmark
*Corresponding author. Tel.: +1 410 706 6962;
fax: +1 410 706 1992
E-mail addresses: ecox@som.umaryland.edu
eric.tiff.cox@gmail.com (E.R. Cox)
